Clinical Trial Update: Angiography Study of BioNIR Drug Eluting Stent System (NIREUS) [Phase 2]

View source ↗

Summary

Phase 2 trial update for the BioNIR Drug Eluting Stent System (NIREUS) in coronary artery stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BioNIR Drug Eluting Stent System (NIREUS)

Snippet

Sponsor: Medinol Ltd. | Conditions: Coronary Artery Stenosis | Phase 2 | Status: COMPLETED